Prof. Francisco Marin

All Stories

The Long-Term Outcomes of Corticosteroid Use in COVID-19 Patients with Cardiovascular Disease: A Propensity-Matched Analysis from the Multi-Center International Prospective Registry (HOPE-2)

Article • Biomedicines, October 2025, MDPI AG

Prof. Francisco Marin
Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and stroke

Article • European Heart Journal - Quality of Care and Clinical Outcomes, August 2025, Oxford University Press (OUP)

Prof. Francisco Marin
Association between baseline adherence to a healthy lifestyle with ischemic and major cardiovascular events in patients with atrial fibrillation

Article • European Journal of Preventive Cardiology, May 2025, Oxford University Press (OUP)

Prof. Francisco Marin
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC‐EHRA EORP Atrial Fibrillation Long‐Term General Registry

Article • Journal of the American Heart Association, January 2025, Wolters Kluwer Health

Prof. Francisco Marin , Nika Kuridze
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

Article • Journal of Clinical Medicine, April 2024, MDPI AG

Prof. Francisco Marin
Reducing bleeding risk in patients on oral anticoagulation therapy

Article • Expert Review of Cardiovascular Therapy, November 2023, Taylor & Francis

Prof. Francisco Marin
Peripheral artery disease: Update on etiology, pathophysiology, diagnosis and treatment

Article • Medicina Clínica, October 2023, Elsevier

Prof. Francisco Marin
Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved

Article • Thrombosis and Haemostasis, September 2023, Thieme Publishing Group

Prof. Francisco Marin
Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases

Article • Thrombosis and Haemostasis, September 2023, Thieme Publishing Group

Prof. Francisco Marin
Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment

Article • The American Journal of Cardiology, September 2023, Elsevier

Prof. Francisco Marin
Prospective observational registry of perioperative and periprocedural management of antithrombotic therapy in “real world”: the REQXAA study

Article • Revista Española de Cardiología (English Edition), September 2023, Elsevier

Prof. Francisco Marin
Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review

Article • The Science of The Total Environment, July 2023, Elsevier

Prof. Francisco Marin
Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients

Article • IJC Heart & Vasculature, June 2023, Elsevier

Prof. Francisco Marin
Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

Article • Frontiers in Endocrinology, May 2023, Frontiers

Prof. Francisco Marin
Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia

Article • Heart & Lung, May 2023, Elsevier

Prof. Francisco Marin
Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea

Article • The FASEB Journal, April 2023, Wiley

Prof. Francisco Marin
Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis

Article • Journal of Clinical Medicine, April 2023, MDPI AG

Prof. Francisco Marin , Miss Clarissa Giebel
Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making

Article • American Heart Journal, April 2023, Elsevier

Prof. Francisco Marin
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban

Article • Journal of Comparative Effectiveness Research, March 2023, Becaris Publishing Limited

Prof. Francisco Marin
Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?

Article • Biomedicine & Pharmacotherapy, February 2023, Elsevier

Prof. Francisco Marin
Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis

Article • European Journal of Internal Medicine, February 2023, Elsevier

Prof. Francisco Marin
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients

Article • Journal of Clinical Medicine, January 2023, MDPI AG

Prof. Francisco Marin
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)

Article • Journal of Clinical Medicine, January 2023, MDPI AG

Prof. Francisco Marin
Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis

Article • Internal and Emergency Medicine, January 2023, Springer Science + Business Media

Prof. Francisco Marin
Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry

Article • European Journal of Internal Medicine, January 2023, Elsevier

Prof. Francisco Marin , Nika Kuridze
Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey

Article • EP Europace, December 2022, Oxford University Press (OUP)

Prof. Francisco Marin , Dr Radoslaw Lenarczyk
Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

Article • Cardiology Journal, December 2022, VM Media SP. zo.o VM Group SK

Prof. Francisco Marin
Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry

Article • EP Europace, November 2022, Oxford University Press (OUP)

Prof. Francisco Marin , Nika Kuridze
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry

Article • European Journal of Internal Medicine, November 2022, Elsevier

Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin , Nika Kuridze, Dr Radoslaw Lenarczyk
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries

Article • Journal of Comparative Effectiveness Research, November 2022, Becaris Publishing Limited

Prof. Francisco Marin
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry

Article • European Heart Journal - Cardiovascular Pharmacotherapy, November 2022, Oxford University Press (OUP)

Prof. Francisco Marin
Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system

Article • Frontiers in Cardiovascular Medicine, October 2022, Frontiers

Prof. Francisco Marin
Polypill Strategy in Secondary Cardiovascular Prevention

Article • New England Journal of Medicine, September 2022, New England Journal of Medicine (NEJM/MMS)

Prof HECTOR BUENO, MD, PhD ANTONIO PORTOLES, Prof. Francisco Marin , Prof. Vicente Andrés, Professor Deepak L Bhatt
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

Article • BMC Medicine, September 2022, Springer Science + Business Media

Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin , Nika Kuridze, Dr Radoslaw Lenarczyk
Predicting heart failure in atrial fibrillation patients: What about using biomarkers?

Article • American Heart Journal, September 2022, Elsevier

Prof. Francisco Marin
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

Article • Expert Opinion on Pharmacotherapy, August 2022, Taylor & Francis

Prof. Francisco Marin
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

Article • Age and Ageing, August 2022, Oxford University Press (OUP)

Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin , Nika Kuridze, Dr Radoslaw Lenarczyk
Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program

Article • Medicina Clínica, August 2022, Elsevier

Prof. Francisco Marin
MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction

Article • Journal of Personalized Medicine, July 2022, MDPI AG

Prof. Francisco Marin
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper

Article • Thrombosis and Haemostasis, July 2022, Thieme Publishing Group

Prof. Francisco Marin
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry

Article • Journal of the American Heart Association, July 2022, Wolters Kluwer Health

Prof. Francisco Marin
Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study

Article • Cardiology Journal, July 2022, VM Media SP. zo.o VM Group SK

Prof. Francisco Marin
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation ...

Article • European Journal of Preventive Cardiology, June 2022, Oxford University Press (OUP)

Nika Kuridze, Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin
Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry

Article • European Journal of Preventive Cardiology, June 2022, Oxford University Press (OUP)

Professor Erkin Mirrakhimov, Prof. Francisco Marin , Lucia Cojocaru
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry

Article • International Journal of Clinical Practice, May 2022, Hindawi Publishing Corporation

Prof. Francisco Marin
Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry

Article • Frontiers in Cardiovascular Medicine, May 2022, Frontiers

Prof. Francisco Marin
Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry

Article • European Journal of Internal Medicine, May 2022, Elsevier

Nika Kuridze, Professor Tchavdar N Shalganov, Prof. Francisco Marin
Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry

Article • European Journal of Internal Medicine, May 2022, Elsevier

Nika Kuridze, Prof. Francisco Marin
Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

Article • European Journal of Clinical Investigation, April 2022, Wiley

Prof. Francisco Marin
The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort

Article • Journal of General Internal Medicine, April 2022, Springer Science + Business Media

Prof. Francisco Marin
Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients

Article • European Journal of Internal Medicine, April 2022, Elsevier

Prof. Francisco Marin
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry

Article • European Journal of Clinical Investigation, March 2022, Wiley

Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascul...

Article • EP Europace, March 2022, Oxford University Press (OUP)

Prof. Francisco Marin
Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists

Article • Journal of Personalized Medicine, March 2022, MDPI AG

Prof. Francisco Marin
Clinical implications of diabetes mellitus in patients with acute coronary syndrome: Prognostic role and use of new P2Y12 receptor inhibitors

Article • Diabetes Research and Clinical Practice, February 2022, Elsevier

Prof. Francisco Marin
Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry

Article • European Journal of Clinical Investigation, January 2022, Wiley

Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation

Article • Clinical Research in Cardiology, January 2022, Springer Science + Business Media

Prof. Francisco Marin
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR

Article • New England Journal of Medicine, December 2021, New England Journal of Medicine (NEJM/MMS)

Prof. Francisco Marin
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry

Article • EP Europace, November 2021, Oxford University Press (OUP)

Nika Kuridze, Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin
Antithrombotic therapy and clinical outcomes at 1 year in the Spanish cohort of the EORP‐AF Long‐term General Registry

Article • European Journal of Clinical Investigation, November 2021, Wiley

Prof. Francisco Marin
Impact of sex differences and network systems on the in-hospital mortality of patients with ST-segment elevation acute myocardial infarction

Article • Revista Española de Cardiología (English Edition), November 2021, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

Article • BMC Medicine, October 2021, Springer Science + Business Media

Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin
Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC–EHRA EORP AF Long-Term General Registry

Article • European Heart Journal - Cardiovascular Pharmacotherapy, October 2021, Oxford University Press (OUP)

Nika Kuridze, Prof. Francisco Marin
Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score

Article • Frontiers in Medicine, October 2021, Frontiers

Prof. Francisco Marin
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry

Article • Heart, October 2021, BMJ

Prof. Francisco Marin
Relationship between multimorbidity and outcomes in atrial fibrillation

Article • Experimental Gerontology, October 2021, Elsevier

Prof. Francisco Marin
Prognosis Impact of Diabetes in Elderly Women and Men with Non-ST Elevation Acute Coronary Syndrome

Article • Journal of Clinical Medicine, September 2021, MDPI AG

Dr Gonzalo L Alonso Salinas, Prof. Francisco Marin
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases

Article • Cardiovascular Diabetology, September 2021, Springer Science + Business Media

Prof. Francisco Marin
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes

Article • Thrombosis Research, September 2021, Elsevier

Prof. Francisco Marin
Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

Article • Revista Española de Cardiología (English Edition), September 2021, Elsevier

Prof. Francisco Marin
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry

Article • Clinical Research in Cardiology, August 2021, Springer Science + Business Media

Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin
COVID‐19 and the impact of arterial hypertension—An analysis of the international HOPE COVID‐19 Registry (Italy‐Spain‐Germany)

Article • European Journal of Clinical Investigation, August 2021, Wiley

Prof. Francisco Marin
Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry

Article • EP Europace, August 2021, Oxford University Press (OUP)

Prof. Francisco Marin
Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS

Article • Journal of Clinical Medicine, July 2021, MDPI AG

Prof. Francisco Marin
Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real‐world vs. clinical‐trial evidence

Article • British Journal of Clinical Pharmacology, July 2021, Wiley

Prof. Francisco Marin
In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide Spanish database

Article • Cardiology Journal, July 2021, VM Media SP. zo.o VM Group SK

Prof HECTOR BUENO, Prof. Francisco Marin
Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation

Article • International Journal of Molecular Sciences, July 2021, MDPI AG

Prof. Francisco Marin
Fibrilación auricular en pacientes con COVID-19. Utilidad de la puntuación CHA2DS2-VASc: un análisis del registro internacional HOPE COVID-19

Article • Revista Española de Cardiología, July 2021, Elsevier

Prof. Francisco Marin
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

Article • Revista Española de Cardiología (English Edition), July 2021, Elsevier

Prof. Francisco Marin
Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry

Article • EP Europace, June 2021, Oxford University Press (OUP)

Prof. Francisco Marin
Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation

Article • Revista Española de Cardiología (English Edition), May 2021, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study)

Article • Journal of Comparative Effectiveness Research, May 2021, Becaris Publishing Limited

Prof. Francisco Marin
Underlying heart diseases and acute COVID-19 outcomes

Article • Cardiology Journal, April 2021, VM Media SP. zo.o VM Group SK

Prof. Francisco Marin
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])

Article • Critical Care Medicine, April 2021, Wolters Kluwer Health

Prof. Francisco Marin
Baseline CHA 2 DS 2 ‐VASc score and prognosis in octogenarians with non‐ST segment elevation acute coronary syndrome

Article • International Journal of Clinical Practice, March 2021, Hindawi Publishing Corporation

Prof HECTOR BUENO, Prof. Francisco Marin
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

Article • Diabetes Care, March 2021, American Diabetes Association

Prof. Francisco Marin , Professor Deepak L Bhatt
Sex bias in admission to tertiary‐care centres for acute myocardial infarction and cardiogenic shock

Article • European Journal of Clinical Investigation, March 2021, Wiley

Prof HECTOR BUENO, Prof. Francisco Marin
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry

Article • Infection, March 2021, Springer Science + Business Media

Prof. Francisco Marin
Impact of frailty and atrial fibrillation in elderly patients with acute coronary syndromes

Article • European Journal of Clinical Investigation, February 2021, Wiley

Prof HECTOR BUENO, Prof. Francisco Marin
Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications

Article • Journal of Clinical Medicine, February 2021, MDPI AG

Prof. Francisco Marin
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry

Article • February 2021, Research Square

Prof. Francisco Marin
Novel insights in the relationship of gut microbiota and coronary artery diseases

Article • Critical Reviews in Food Science and Nutrition, January 2021, Taylor & Francis

Prof. Francisco Marin
Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience from the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score

Article • SSRN Electronic Journal, January 2021, Elsevier

Prof. Francisco Marin
Outcomes in VKA‐treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs ‘real‐world’

Article • International Journal of Clinical Practice, December 2020, Hindawi Publishing Corporation

Prof. Francisco Marin
The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing an...

Article • EP Europace, December 2020, Oxford University Press (OUP)

Prof. Francisco Marin
Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores

Article • Thrombosis and Haemostasis, December 2020, Thieme Publishing Group

Prof. Francisco Marin
Factor XI, much more than an innocent observer

Article • Journal of Thrombosis and Haemostasis, December 2020, Elsevier

Prof. Francisco Marin
Influence of the matrix type over the concentration of GDF-15

Article • Journal of Investigative Medicine, December 2020, SAGE Publications

Prof. Francisco Marin
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis

Article • Frontiers in Endocrinology, November 2020, Frontiers

Prof. Francisco Marin
Incidence and outcomes of hospital treated acute myocarditis from 2003 to 2015 in Spain

Article • European Journal of Clinical Investigation, November 2020, Wiley

Prof HECTOR BUENO, Prof. Francisco Marin
Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation

Article • Journal of Clinical Medicine, November 2020, MDPI AG

Prof. Francisco Marin
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

Article • Internal and Emergency Medicine, November 2020, Springer Science + Business Media

Prof. Francisco Marin
Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID‐19

Article • European Journal of Clinical Investigation, November 2020, Wiley

Prof. Francisco Marin
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry

Article • European Journal of Clinical Investigation, November 2020, Wiley

Prof. Francisco Marin
Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation

Article • Mayo Clinic Proceedings, November 2020, Elsevier

Prof. Francisco Marin
Impacto del tratamiento antitrombótico y los síndromes geriátricos en octogenarios con fibrilación auricular y cardiopatía isquémica. Fibrilación Auricular y Cardiopatía Isquémica en Longevos (FACIL)

Article • Revista Española de Geriatría y Gerontología, November 2020, Elsevier

Prof. Francisco Marin
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry

Article • EP Europace, October 2020, Oxford University Press (OUP)

Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin
Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response

Article • Expert Review of Precision Medicine and Drug Development, September 2020, Taylor & Francis

Prof. Francisco Marin
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology

Article • Revista Española de Cardiología (English Edition), September 2020, Elsevier

Prof. Francisco Marin
Recomendaciones sobre el tratamiento antitrombótico durante la pandemia COVID-19. Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Española de Cardiología

Article • Revista Española de Cardiología, September 2020, Elsevier

Prof. Francisco Marin
Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial

Article • European Heart Journal, August 2020, Oxford University Press (OUP)

Prof. Francisco Marin
A nurse‐led atrial fibrillation clinic: Impact on anticoagulation therapy and clinical outcomes

Article • International Journal of Clinical Practice, August 2020, Hindawi Publishing Corporation

Prof. Francisco Marin
Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study

Article • European Journal of Internal Medicine, August 2020, Elsevier

Prof. Francisco Marin
Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy

Article • Expert Opinion on Pharmacotherapy, July 2020, Taylor & Francis

Prof. Francisco Marin
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry

Article • Journal of Nephrology, June 2020, Springer Science + Business Media

Prof. Francisco Marin
Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry

Article • Annals of Medicine, June 2020, Taylor & Francis

Prof. Francisco Marin
Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project

Article • Thrombosis and Haemostasis, June 2020, Thieme Publishing Group

Prof. Francisco Marin
Comments on the 2019 ESC guidelines on chronic coronary syndromes

Article • Revista Española de Cardiología (English Edition), June 2020, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Comments on the 2019 ESC guidelines on acute pulmonary embolism

Article • Revista Española de Cardiología (English Edition), June 2020, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin , Luis Jara-Palomares
Comments on the 2019 ESC guidelines on supraventricular tachycardia

Article • Revista Española de Cardiología (English Edition), June 2020, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
FRAIL Scale also Predicts Long-Term Outcomes in Older Patients With Acute Coronary Syndromes

Article • Journal of the American Medical Directors Association, May 2020, Elsevier

Prof. Francisco Marin
Prognostic impact of inappropriate doses of direct oral anticoagulants in clinical practice

Article • Revista Española de Cardiología (English Edition), April 2020, Elsevier

Prof. Francisco Marin
Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a “Real-world” Nationwide Registry: Insights From the FANTASIIA Study

Article • Journal of Cardiovascular Pharmacology and Therapeutics, March 2020, SAGE Publications

Prof. Francisco Marin
Comments on the 2019 ESC guidelines on diabetes, prediabetes, and cardiovascular disease

Article • Revista Española de Cardiología (English Edition), March 2020, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias

Article • Revista Española de Cardiología (English Edition), March 2020, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Early Small Creatinine Shift Predicts Contrast-Induced Acute Kidney Injury and Persistent Renal Damage after Percutaneous Coronary Procedures

Article • Cardiovascular Revascularization Medicine, March 2020, Elsevier

Prof. Francisco Marin
One‐year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry

Article • British Journal of Clinical Pharmacology, February 2020, Wiley

Prof. Francisco Marin
Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry

Article • Journal of the American Heart Association, January 2020, Wolters Kluwer Health

Prof. Francisco Marin
Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation

Article • BMJ Open, December 2019, BMJ

Prof. Francisco Marin
‘Real-world’ observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin Ame...

Article • EP Europace, November 2019, Oxford University Press (OUP)

Prof. Francisco Marin
Are There Gaps in the Evidence on the Treatment of Mild Hypertension in Patients With Low Cardiovascular Risk? Response

Article • Revista Española de Cardiología (English Edition), October 2019, Elsevier

Prof. Francisco Marin
Optimized scoring tool to quantify the functional performance during the sit-to-stand transition with a magneto-inertial measurement unit

Article • Clinical Biomechanics, October 2019, Elsevier

Prof. Francisco Marin
Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: results of the European Heart Rhythm Association survey

Article • EP Europace, September 2019, Oxford University Press (OUP)

Prof. Francisco Marin , Dr Radoslaw Lenarczyk
The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal

Article • Thrombosis and Haemostasis, September 2019, Thieme Publishing Group

Prof. Francisco Marin
High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers

Article • Journal of Medical Genetics, September 2019, BMJ

Pilar Guerra-Garcia, Prof. Francisco Marin
Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations

Article • Revista Española de Cardiología (English Edition), September 2019, Elsevier

Dr Gonzalo L Alonso Salinas, Prof. Francisco Marin
Reply to: Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials

Article • Journal of Bone and Mineral Research, August 2019, Oxford University Press (OUP)

Prof. Francisco Marin
A colorimetric method for the determination of different functional flavonoids using 2,2'-azino-bis-(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) and peroxidase

Article • Preparative Biochemistry & Biotechnology, August 2019, Taylor & Francis

Prof. Francisco Marin
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Article • The Lancet Diabetes & Endocrinology, August 2019, Elsevier

Professor Thomas Munzel or Muenzel, Prof. Francisco Marin , Professor Deepak L Bhatt
Optimal marker set assessment for motion capture of 3D mimic facial movements

Article • Journal of Biomechanics, August 2019, Elsevier

Prof. Francisco Marin
Epidemiology of Cardiac Myxoma in a Spanish Population. A 30-year Surgical Series

Article • Revista Española de Cardiología (English Edition), August 2019, Elsevier

Prof. Francisco Marin
Antisynthetase Syndrome and Autoantibodies: A Literature Review and Report of 4 Cases

Article • American Journal of Case Reports, July 2019, International Scientific Literature

Prof. Francisco Marin
Under-prescription of novel antiplatelet drugs in patients with acute coronary syndrome and previous cardiovascular disease

Article • Minerva Medica, July 2019, Edizioni Minerva Medica

Prof. Francisco Marin
Mid-upper arm circumference predicts death in adult patients admitted to a TB ward in the Philippines: A prospective cohort study

Article • PLOS One, June 2019, PLOS

Prof. Francisco Marin
Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores

Article • Stroke, June 2019, Wolters Kluwer Health

Prof. Francisco Marin
Performance of alternative measures to body mass index in the assessment of moderate and severe under-nutrition among acutely unwell patients hospitalized in a TB ward in the Philippines: A cross-sectional study

Article • PLOS One, May 2019, PLOS

Prof. Francisco Marin
Devices for mechanical circulatory support and strategies for their management in cardiogenic shock

Article • Kardiologia Polska, May 2019, Polskie Towarzystwo Kardiologiczne

Prof. Francisco Marin
'Palaeoshellomics’ reveals the use of freshwater mother-of-pearl in prehistory

Article • eLife, May 2019, eLife

Prof. Francisco Marin
Mitral Regurgitation and Prognosis After Non‐ST‐Segment Elevation Myocardial Infarction in Very Old Patients

Article • Journal of the American Geriatrics Society, May 2019, Wiley

Prof HECTOR BUENO, Prof. Francisco Marin
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

Article • Thrombosis Journal, April 2019, Springer Science + Business Media

Prof. Francisco Marin
Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

Article • Scientific Reports, April 2019, Springer Science + Business Media

Prof. Francisco Marin
Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome

Article • European Journal of Internal Medicine, April 2019, Elsevier

Prof HECTOR BUENO, Francesc Formiga, Prof. Francisco Marin
Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey

Article • EP Europace, March 2019, Oxford University Press (OUP)

Dr Radoslaw Lenarczyk, Prof. Francisco Marin
High and low on-treatment platelet reactivity to P2Y12 inhibitors in a contemporary cohort of acute coronary syndrome patients undergoing percutaneous coronary intervention

Article • Thrombosis Research, March 2019, Elsevier

Prof. Francisco Marin
Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome

Article • European Journal of Internal Medicine, March 2019, Elsevier

Prof. Francisco Marin
Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis

Article • Bone, March 2019, Elsevier

Prof. Francisco Marin
Comments on the 2018 ESC Guidelines for the Management of Cardiovascular Diseases During Pregnancy

Article • Revista Española de Cardiología (English Edition), February 2019, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Comments on the 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension

Article • Revista Española de Cardiología (English Edition), February 2019, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design

Article • Revista Española de Cardiología (English Edition), February 2019, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Toward mechanistic models for genotype–phenotype correlations in phenylketonuria using protein stability calculations

Article • Human Mutation, January 2019, Hindawi Publishing Corporation

Prof. Francisco Marin
Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials

Article • Journal of Bone and Mineral Research, January 2019, Oxford University Press (OUP)

Prof. Francisco Marin
Diabetes mellitus, frailty and prognosis in very elderly patients with acute coronary syndromes

Article • Aging Clinical and Experimental Research, January 2019, Springer Science + Business Media

Prof HECTOR BUENO, Prof. Francisco Marin
A voxel-based method for designing a numerical biomechanical model patient-specific with an anatomical functional approach adapted to additive manufacturing

Article • Computer Methods in Biomechanics & Biomedical Engineering, January 2019, Taylor & Francis

Prof. Francisco Marin
Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial

Article • Archives of Osteoporosis, January 2019, Springer Science + Business Media

Prof. Francisco Marin
Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis

Article • Clinical Drug Investigation, January 2019, Springer Science + Business Media

Prof. Francisco Marin
OUP accepted manuscript

Article • EP Europace, January 2019, Oxford University Press (OUP)

Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin
Statin Treatment and Prognosis of Elderly Patients Discharged after Non-ST Segment Elevation Acute Coronary Syndrome

Article • Cardiology, January 2019, Karger Publishers

Prof HECTOR BUENO, Prof. Francisco Marin
Comments on the 2018 ESC Fourth Universal Definition of Myocardial Infarction

Article • Revista Española de Cardiología (English Edition), January 2019, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Comments on the 2018 ESC/EACTS Guidelines for Myocardial Revascularization

Article • Revista Española de Cardiología (English Edition), January 2019, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Bleeding Risk Prediction in Patients With Dual Antiplatelet Therapy Undergoing Coronary Artery Bypass Grafting Surgery Using a Rapid Point-of-Care Platelet Function Test

Article • Circulation Cardiovascular Interventions, December 2018, Wolters Kluwer Health

Prof. Francisco Marin
Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines

Article • PLOS One, November 2018, PLOS

Prof. Francisco Marin
Study description and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide in postmenopausal women with osteoporosis: the Asia and Latin America Fracture Observational Study (ALAFOS)

Article • Current Medical Research and Opinion, November 2018, Taylor & Francis

Dr Chung-Hwan Chen, Abdulaziz Elsalmawy, Prof. Francisco Marin
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Article • New England Journal of Medicine, November 2018, New England Journal of Medicine (NEJM/MMS)

Professor Deepak L Bhatt, Dr Tuomas O Kiviniemi, Professor Thomas Munzel or Muenzel, Prof. Francisco Marin
Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies

Article • Bone, November 2018, Elsevier

Prof. Francisco Marin
Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists

Article • QJM, October 2018, Oxford University Press (OUP)

Prof. Francisco Marin
A multi‐layered nerve guidance conduit design adapted to facilitate surgical implantation

Article • Health Science Reports, October 2018, Wiley

Prof. Francisco Marin
Reduction of Hip and Other Fractures in Patients Receiving Teriparatide in Real-World Clinical Practice: Integrated Analysis of Four Prospective Observational Studies

Article • Calcified Tissue International, October 2018, Springer Science + Business Media

Prof. Francisco Marin
Identification of Noise Covariance Matrices to Improve Orientation Estimation by Kalman Filter

Article • Sensors, October 2018, MDPI AG

Prof. Francisco Marin
Comments on the 2018 ESC Guidelines for the Diagnosis and Management of Syncope

Article • Revista Española de Cardiología (English Edition), October 2018, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores

Article • Journal of the American Heart Association, September 2018, Wolters Kluwer Health

María Asunción Esteve-Pastor, Dr Marco Proietti, Prof. Francisco Marin
Chronic Kidney Disease and Third-Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year

Article • The Journal of Clinical Pharmacology, September 2018, Wiley

María Asunción Esteve-Pastor, Prof. Francisco Marin
Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated “Real-World” in Patients With Atrial Fibrillation

Article • The American Journal of Cardiology, September 2018, Elsevier

Prof. Francisco Marin
Biochemical characterization of the skeletal matrix of the massive coral, Porites australiensis – The saccharide moieties and their localization

Article • Journal of Structural Biology, September 2018, Elsevier

Prof. Francisco Marin
Teriparatide Treatment Increases Mineral Content and Volume in Cortical and Trabecular Bone of Iliac Crest: A Comparison of Infrared Imaging With X-Ray–Based Bone Assessment Techniques

Article • Journal of Bone and Mineral Research, August 2018, Oxford University Press (OUP)

Prof. Francisco Marin
Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification

Article • The FASEB Journal, August 2018, Federation of American Societies For Experimental Biology (FASEB)

Dr Cristina Rodriguez, Prof. Francisco Marin
Oral anticoagulation and comorbidities; too many details for clinical practice?

Article • International Journal of Cardiology, August 2018, Elsevier

Prof. Francisco Marin
A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials

Article • Mayo Clinic Proceedings, August 2018, Elsevier

Prof. Francisco Marin
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the Eu...

Article • EP Europace, July 2018, Oxford University Press (OUP)

Prof HECTOR BUENO, Prof. Francisco Marin
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU

Article • Revista Española de Cardiología (English Edition), July 2018, Elsevier

Prof. Francisco Marin
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: Biomarker substudy results from a prospective study with rivaroxaban (X-TRA)

Article • Annals of Medicine, June 2018, Taylor & Francis

Kazuo Miyazawa, Prof. Francisco Marin
Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS)

Article • Calcified Tissue International, June 2018, Springer Science + Business Media

Prof. Francisco Marin , Tomaž Kocjan
European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), C...

Article • EP Europace, June 2018, Oxford University Press (OUP)

Dr Radoslaw Lenarczyk, Prof. Francisco Marin
Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey

Article • EP Europace, June 2018, Oxford University Press (OUP)

Dr Radoslaw Lenarczyk, Prof. Francisco Marin
Invasive strategy and frailty in very elderly patients with acute coronary syndromes

Article • EuroIntervention, June 2018, Europa Digital & Publishing

Prof HECTOR BUENO, Prof. Francisco Marin
Wnt Signaling Pathways Are Dysregulated in Rat Female Cerebellum Following Early Methyl Donor Deficiency

Article • Molecular Neurobiology, May 2018, Springer Science + Business Media

Prof. Francisco Marin
Molecular modularity and asymmetry of the molluscan mantle revealed by a gene expression atlas

Article • GigaScience, May 2018, Oxford University Press (OUP)

Prof. Francisco Marin
Teriparatide vs risedronate for osteoporosis – Authors' reply

Article • The Lancet, May 2018, Elsevier

Prof. Francisco Marin
Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft‐Gault, Modification of Diet in Renal Disease‐4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronar...

Article • Journal of the American Heart Association, April 2018, Wolters Kluwer Health

María Asunción Esteve-Pastor, Prof. Francisco Marin
Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation

Article • European Journal of Clinical Investigation, April 2018, Wiley

María Asunción Esteve-Pastor, Prof. Francisco Marin
Optimizing Vitamin K Antagonist Treatment in Patients with Mechanical Heart Valve Prosthesis

Article • Thrombosis and Haemostasis, April 2018, Thieme Publishing Group

Prof. Francisco Marin
Plant Lineage-Specific Amplification of Transcription Factor Binding Motifs by Miniature Inverted-Repeat Transposable Elements (MITEs)

Article • Genome Biology and Evolution, April 2018, Oxford University Press (OUP)

Prof. Francisco Marin
An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes

Article • Journal of the American Medical Directors Association, April 2018, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Design-validation of a hand exoskeleton using musculoskeletal modeling

Article • Applied Ergonomics, April 2018, Elsevier

Prof. Francisco Marin
Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project

Article • Journal of General Internal Medicine, March 2018, Springer Science + Business Media

Prof. Francisco Marin
European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)

Article • EP Europace, March 2018, Oxford University Press (OUP)

Prof. Francisco Marin
Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry

Article • European Journal of Clinical Investigation, March 2018, Wiley

Prof. Francisco Marin
Modeling and simulation of different and representative engineering problems using Network Simulation Method

Article • PLOS One, March 2018, PLOS

Prof. Francisco Marin
Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in ‘real-world’ atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients

Article • International Journal of Cardiology, March 2018, Elsevier

Prof. Francisco Marin
Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA 2 DS 2 -VASc and HAS-BLED

Article • American Heart Journal, March 2018, Elsevier

Prof. Francisco Marin
Intra-ventricular thrombus resolution after anticoagulation therapy with rivaroxaban in patient with poor anticoagulation quality

Article • Cardiology Journal, February 2018, VM Media SP. zo.o VM Group SK

Prof. Francisco Marin
Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality

Article • International Journal of Clinical Practice, February 2018, Wiley

María Asunción Esteve-Pastor, Prof. Francisco Marin
Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial

Article • Journal of Bone and Mineral Research, February 2018, Wiley

Professor Salvatore MINISOLA, Prof. Francisco Marin
The growth of interest for astronomical X-ray polarimetry

Article • February 2018, MDPI AG

Prof. Francisco Marin
Global Geriatric Assessment and In-Hospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVO-SCA Registry

Article • Thrombosis and Haemostasis, February 2018, Thieme Publishing Group

Prof HECTOR BUENO, Prof. Francisco Marin
Comments on the 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases

Article • Revista Española de Cardiología (English Edition), February 2018, Elsevier

Prof. Francisco Marin
Comments on the 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease

Article • Revista Española de Cardiología (English Edition), February 2018, Elsevier

Prof. Francisco Marin
Imaging Correlations in Heterodyne Spectra for Quantum Displacement Sensing

Article • Physical Review Letters, January 2018, American Physical Society (APS)

Prof. Francisco Marin
Polyphenolic Compounds, Antioxidant, and Cardioprotective Effects of Pomace Extracts from Fetească Neagră Cultivar

Article • Oxidative Medicine and Cellular Longevity, January 2018, Hindawi Publishing Corporation

Parvu Marcel, Prof. Francisco Marin
A new twist on sea silk: the peculiar protein ultrastructure of fan shell and pearl oyster byssus

Article • Soft Matter, January 2018, Royal Society of Chemistry

Prof. Francisco Marin
Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients

Article • Circulation Journal, January 2018, Japanese Circulation Society

Prof. Francisco Marin
Comments on the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease

Article • Revista Española de Cardiología (English Edition), January 2018, Elsevier

Prof. Francisco Marin
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy

Article • Circulation Heart Failure, January 2018, Wolters Kluwer Health

Prof. Francisco Marin
Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry

Article • Thrombosis and Haemostasis, January 2018, Thieme Publishing Group

Prof. Francisco Marin
Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol

Article • Clinical Therapeutics, January 2018, Elsevier

Prof. Francisco Marin
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

Article • The Lancet, January 2018, Elsevier

Prof. Francisco Marin
Temporal Changes in Platelet Response in Acute Coronary Syndrome Patients With Prasugrel and Clopidogrel After Stent Implantation

Article • Circulation Journal, January 2018, Japanese Circulation Society

Prof. Francisco Marin
Comments on the 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-segment Elevation

Article • Revista Española de Cardiología (English Edition), December 2017, Elsevier

Prof HECTOR BUENO, Prof. Francisco Marin
Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation

Article • The American Journal of Cardiology, December 2017, Elsevier

Prof. Francisco Marin
Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry

Article • EP Europace, November 2017, Oxford University Press (OUP)

Prof. Francisco Marin
Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS)

Article • EP Europace, November 2017, Oxford University Press (OUP)

Prof. Francisco Marin
Effects of a trail mountain race on neuromuscular performance and hydration status in trained runners

Article • The Journal of Sports Medicine and Physical Fitness, November 2017, Edizioni Minerva Medica

Prof. Francisco Marin
Quality of oral anticoagulation with vitamin K antagonists in ‘real-world’ patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry

Article • EP Europace, October 2017, Oxford University Press (OUP)

Prof. Francisco Marin
Estimation of the wrist joint center of rotation

Article • Computer Methods in Biomechanics & Biomedical Engineering, October 2017, Taylor & Francis

Prof. Francisco Marin
Motion analysis of snare drum in relation with the musician’s expertise

Article • Computer Methods in Biomechanics & Biomedical Engineering, October 2017, Taylor & Francis

Prof. Francisco Marin
Emotional concerns and coping strategies in Low Grade Glioma patients and reliability of their caregivers in reporting these concerns: Findings from a cross-sectional study

Article • European Journal of Oncology Nursing, October 2017, Elsevier

Prof. Francisco Marin
Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation

Article • Drug Discovery Today, October 2017, Elsevier

Prof. Francisco Marin
Research update for articles published in EJCI in 2015

Article • European Journal of Clinical Investigation, September 2017, Wiley

Dr Federico Carbone, Dr. Ozra Tabatabaei-Malazy, Prof. Francisco Marin
Therapeutic management and one-year outcomes in elderly patients with acute coronary syndrome

Article • Oncotarget, September 2017, Impact Journals, LLC

Prof. Francisco Marin
Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

Article • Scientific Reports, September 2017, Springer Science + Business Media

Prof. Francisco Marin
Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA2DS2-VASc and HAS-BLED scores using multiple biomarkers

Article • Annals of Medicine, September 2017, Taylor & Francis

Prof. Francisco Marin
Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry

Article • EP Europace, September 2017, Oxford University Press (OUP)

Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Nika Kuridze, Prof. Francisco Marin
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Worki...

Article • EP Europace, August 2017, Oxford University Press (OUP)

Prof. Francisco Marin
Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes

Article • Journal of Cardiovascular Pharmacology and Therapeutics, August 2017, SAGE Publications

Prof. Francisco Marin
Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation

Article • Expert Opinion on Drug Safety, July 2017, Taylor & Francis

María Asunción Esteve-Pastor, Prof. Francisco Marin
Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad ...

Article • EP Europace, July 2017, Oxford University Press (OUP)

Prof. Francisco Marin
The future of nutrition: Nutrigenomics and nutrigenetics in obesity and cardiovascular diseases

Article • Critical Reviews in Food Science and Nutrition, July 2017, Taylor & Francis

Prof. Francisco Marin
Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisio...

Article • EP Europace, July 2017, Oxford University Press (OUP)

Prof. Francisco Marin
Percutaneous cryoablation of symptomatic venous malformations as a second-line therapeutic option: a five-year single institution experience

Article • European Radiology, July 2017, Springer Science + Business Media

Prof. Francisco Marin
Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA 2 DS 2 ‐VASc Scores

Article • Journal of the American Heart Association, July 2017, Wolters Kluwer Health

María Asunción Esteve-Pastor, Prof. Francisco Marin
Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoameri...

Article • EP Europace, June 2017, Oxford University Press (OUP)

Professor Antonis S Manolis, Prof. Francisco Marin
Hypertension and Cardiac Arrhythmias: Executive Summary of a Consensus Document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and...

Article • European Heart Journal - Cardiovascular Pharmacotherapy, May 2017, Oxford University Press (OUP)

Professor Antonis S Manolis, Prof. Francisco Marin
Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome

Article • Critical Reviews in Food Science and Nutrition, May 2017, Taylor & Francis

Prof. Francisco Marin
Low body weight and clinical outcomes in acute coronary syndrome patients: results of the ACHILLES Registry

Article • European Journal of Cardiovascular Nursing, May 2017, SAGE Publications

Prof. Francisco Marin
Shell extracts of the edible mussel and oyster induce an enhancement of the catabolic pathway of human skin fibroblasts, in vitro

Article • Cytotechnology, May 2017, Springer Science + Business Media

Prof. Francisco Marin
Analysis of the sEMG/force relationship using HD-sEMG technique and data fusion: A simulation study

Article • Computers in Biology and Medicine, April 2017, Elsevier

Prof. Francisco Marin
Micronutrient supplementation in gastric bypass surgery: prospective study on inﬂammation and iron metabolism in premenopausal women

Article • Nutrición Hospitalaria, March 2017, Sociedad Espanola de Nutricion Parenteral y Enteral (SENPE)

Prof. Francisco Marin
Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice

Article • Expert Review of Cardiovascular Therapy, March 2017, Taylor & Francis

Prof. Francisco Marin
Applicability of the modified CHA 2 DS 2 -VASc score for stroke risk stratification in Caucasian atrial fibrillation patients

Article • European Journal of Internal Medicine, March 2017, Elsevier

Prof. Francisco Marin
The Changing Landscape for Stroke Prevention in AF

Article • Journal of the American College of Cardiology, February 2017, Elsevier

Professor Catarina Fonseca, Dr Radoslaw Lenarczyk, M.D Ph.D Serge Timsit, Mr JOSE A. CALVO-MANZANO, Prof. Francisco Marin
Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants

Article • Revista Española de Cardiología (English Edition), February 2017, Elsevier

Prof. Francisco Marin
Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

Article • Scientific Reports, January 2017, Springer Science + Business Media

Prof. Francisco Marin
Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial

Article • Journal of Bone and Mineral Research, January 2017, Wiley

Dr. Kyriakos A Papavasiliou , DR. JORGE MALOUF-SIERRA, Prof. Francisco Marin
Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation

Article • Scientific Reports, January 2017, Springer Science + Business Media

Prof. Francisco Marin
Search for an Ultralight Scalar Dark Matter Candidate with the AURIGA Detector

Article • Physical Review Letters, January 2017, American Physical Society (APS)

Prof. Francisco Marin
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endo...

Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

Prof. Francisco Marin
Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

Prof. Francisco Marin
Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores

Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

Prof. Francisco Marin
Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

Prof. Francisco Marin
Predicting bleeding risk after coronary surgery: Let’s focus on modifiable risk factors and simple, practical decision making

Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

Prof. Francisco Marin
Comments on the 2016 ESC Guidelines for the Management of Atrial Fibrillation

Article • Revista Española de Cardiología (English Edition), January 2017, Elsevier

Prof. Francisco Marin
Deep conservation of bivalve nacre proteins highlighted by shell matrix proteomics of the Unionoida Elliptio complanata and Villosa lienosa

Article • Journal of The Royal Society Interface, January 2017, Royal Society Publishing

Prof. Francisco Marin
Deciphering acute coronary syndrome biomarkers: High-resolution proteomics in platelets, thrombi and microparticles

Article • Critical Reviews in Clinical Laboratory Sciences, December 2016, Taylor & Francis

Prof. Francisco Marin
Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation

Article • Expert Opinion on Pharmacotherapy, December 2016, Taylor & Francis

Prof. Francisco Marin
Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor

Article • Advances in Therapy, December 2016, Springer Science + Business Media

Prof. Francisco Marin
Formation of localized sand patterns downstream from a vertical cylinder under steady flows: Experimental and theoretical study

Article • November 2016, American Physical Society (APS)

Prof. Francisco Marin
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society ...

Article • European Journal of Preventive Cardiology, November 2016, Oxford University Press (OUP)

Prof. Francisco Marin
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society ...

Article • EP Europace, November 2016, European Society of Cardiology

Prof. Francisco Marin
Teriparatide and Risedronate After Hip Fracture

Article • Journal of Bone and Joint Surgery, November 2016, The Journal of Bone and Joint Surgery, Inc.

Professor Søren Overgaard, DR. JORGE MALOUF-SIERRA, José R. Caeiro, Dr. Kyriakos A Papavasiliou , Eric LESPESSAILLES, Prof. Francisco Marin
Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low–moderate risk of stroke?

Article • European Journal of Internal Medicine, November 2016, Elsevier

Prof. Francisco Marin
Oral anticoagulation in octogenarians with atrial fibrillation

Article • International Journal of Cardiology, November 2016, Elsevier

Prof. Francisco Marin
Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST elevation myocardial infarction

Article • European Journal of Internal Medicine, November 2016, Elsevier

Prof. Francisco Marin
Organic matrices in metazoan calcium carbonate skeletons: Composition, functions, evolution

Article • Journal of Structural Biology, November 2016, Elsevier

Prof. Francisco Marin
Expression patterns of Irx genes in the developing chick inner ear

Article • Brain Structure and Function, October 2016, Springer Science + Business Media

Professor Luis Puelles, Prof. Francisco Marin
The wearable cardioverter-defibrillator: current technology and evolving indications

Article • EP Europace, October 2016, European Society of Cardiology

Prof. Francisco Marin
Structural Heart Disease in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Prevalence and Clinical Profile in a Spanish Sample

Article • Revista Española de Cardiología (English Edition), October 2016, Elsevier

Prof. Francisco Marin
Sport, health and sudden death

Article • International Journal of Cardiology, October 2016, Elsevier

Prof. Francisco Marin
Classification of physical activities based on body-segments coordination

Article • Computers in Biology and Medicine, September 2016, Elsevier

Prof. Francisco Marin
Extraction of the Brachialis muscle activity using HD-sEMG technique and canonical correlation analysis

Article • August 2016, Institute of Electrical & Electronics Engineers (IEEE)

Prof. Francisco Marin
Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)

Article • American Heart Journal, August 2016, Elsevier

Prof. Francisco Marin
The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion

Article • International Journal of Cardiology, August 2016, Elsevier

Prof. Francisco Marin
Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy

Article • Current Medicinal Chemistry, July 2016, Bentham Science Publishers

Assistant Professor Tatjana S Potpara, Prof. Francisco Marin
Strategies for prediction and early detection of atrial fibrillation: present and future

Article • EP Europace, July 2016, European Society of Cardiology

Prof. Francisco Marin
Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold

Article • Platelets, June 2016, Taylor & Francis

Prof. Francisco Marin
Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome

Article • Clinical Cardiology, June 2016, Wiley

Prof. Francisco Marin
On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013

Article • Revista Española de Cardiología (English Edition), June 2016, Elsevier

Prof. Francisco Marin
Validation of a method for noninvasive prenatal testing for fetal aneuploidies risk and considerations for its introduction in the Public Health System

Article • The Journal of Maternal-Fetal & Neonatal Medicine, May 2016, Taylor & Francis

Prof. Francisco Marin
Denoising of HD-sEMG signals using canonical correlation analysis

Article • Medical & Biological Engineering & Computing, May 2016, Springer Science + Business Media

Prof. Francisco Marin
The Shell of the Invasive Bivalve Species Dreissena polymorpha: Biochemical, Elemental and Textural Investigations

Article • PLOS One, May 2016, PLOS

Prof. Francisco Marin
Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer‐based calculation of CHADS2 and CHA2DS2‐VASc scores

Article • Internal Medicine Journal, May 2016, Wiley

Prof. Francisco Marin
miRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients

Article • Annals of Translational Medicine, May 2016, AME Publishing Company

Prof. Francisco Marin
Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies

Article • Molecular Cancer Therapeutics, May 2016, American Association for Cancer Research (AACR)

Prof. Francisco Marin
Evidence From Pacing in Obstructive Hypertrophic Cardiomyopathy

Article • Revista Española de Cardiología (English Edition), May 2016, Elsevier

Prof. Francisco Marin
Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS)

Article • Calcified Tissue International, April 2016, Springer Science + Business Media

Tomaž Kocjan, Prof. Francisco Marin
Testing Quantum Gravity Induced Nonlocality via Optomechanical Quantum Oscillators

Article • Physical Review Letters, April 2016, American Physical Society (APS)

Prof. Francisco Marin
Dynamical Two-Mode Squeezing of Thermal Fluctuations in a Cavity Optomechanical System

Article • Physical Review Letters, March 2016, American Physical Society (APS)

Prof. Francisco Marin
Water-Soluble Compounds from Lentinula edodes Influencing the HMG-CoA Reductase Activity and the Expression of Genes Involved in the Cholesterol Metabolism

Article • Journal of Agricultural and Food Chemistry, March 2016, American Chemical Society (ACS)

Prof. Francisco Marin
A minimal molecular toolkit for mineral deposition? Biochemistry and proteomics of the test matrix of adult specimens of the sea urchin Paracentrotus lividus

Article • Journal of Proteomics, March 2016, Elsevier

Prof. Francisco Marin
New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?

Article • Molecules, February 2016, MDPI AG

Prof. Francisco Marin
Plasma Cholesterol-Lowering Activity of Lard Functionalized with Mushroom Extracts Is Independent of Niemann–Pick C1-like 1 Protein and ABC Sterol Transporter Gene Expression in Hypercholesterolemic Mice

Article • Journal of Agricultural and Food Chemistry, February 2016, American Chemical Society (ACS)

Prof. Francisco Marin
Teriparatide for osteoporosis: importance of the full course

Article • Osteoporosis International, February 2016, Springer Science + Business Media

Prof. Francisco Marin
Prospects for Increasing Sugarcane and Bioethanol Production on Existing Crop Area in Brazil

Article • BioScience, February 2016, Oxford University Press (OUP)

Prof. Francisco Marin
Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion

Article • Circulation Journal, January 2016, Japanese Circulation Society

Prof. Francisco Marin
Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?

Article • Circulation Journal, January 2016, Japanese Circulation Society

María Asunción Esteve-Pastor, Prof. Francisco Marin
Assessment of bleeding risk in acute ill medical patients. An essential part of venous thromboembolism prevention

Article • Thrombosis and Haemostasis, January 2016, Thieme Publishing Group

Prof. Francisco Marin
Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data From the FANTASIIA Registry

Article • Revista Española de Cardiología (English Edition), January 2016, Elsevier

Prof. Francisco Marin
Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy

Article • European Journal of Clinical Investigation, December 2015, Wiley

Prof. Francisco Marin
The SAMe-TT2R2score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation

Article • Expert Review of Cardiovascular Therapy, December 2015, Taylor & Francis

Prof. Francisco Marin
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

Article • New England Journal of Medicine, December 2015, New England Journal of Medicine (NEJM/MMS)

Professor Vladimir V Rafalskiy, Professor john j mcmurray, Prof. Francisco Marin
Nanoscale assembly processes revealed in the nacroprismatic transition zone of Pinna nobilis mollusc shells

Article • Nature Communications, December 2015, Springer Science + Business Media

Prof. Francisco Marin
Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery

Article • EP Europace, November 2015, European Society of Cardiology

Prof. Francisco Marin
The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective ‘Real-world’ Inception Cohort Study

Article • The American Journal of Medicine, November 2015, Elsevier

Prof. Francisco Marin
On the benefits of using HD-sEMG technique for estimating muscle force

Article • Computer Methods in Biomechanics & Biomedical Engineering, September 2015, Taylor & Francis

Prof. Francisco Marin
Clinical development of rivaroxaban: emerging new clinical evidences?

Article • Future Cardiology, September 2015, Future Medicine

Prof. Francisco Marin
Trastornos del desarrollo en niños y adolescentes de la región de Los Ríos, Valdivia, Chile, 2006-2008

Article • Revista chilena de pediatría, September 2015, Sociedad Chilena de Pediatria

Prof. Francisco Marin
Friction coefficient analysis during high-heeled gait

Article • Computer Methods in Biomechanics & Biomedical Engineering, August 2015, Taylor & Francis

Prof. Francisco Marin
3D location deduced by inertial measurement units: a challenging problem

Article • Computer Methods in Biomechanics & Biomedical Engineering, August 2015, Taylor & Francis

Prof. Francisco Marin
Proposition, identification, and experimental evaluation of an inverse dynamic neuromusculoskeletal model for the human finger

Article • Computers in Biology and Medicine, August 2015, Elsevier

Prof. Francisco Marin
Motion capture for functional analysis of new biomaterials in a small animal model

Article • Computer Methods in Biomechanics & Biomedical Engineering, July 2015, Taylor & Francis

Prof. Francisco Marin
Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation

Article • Journal of Cardiovascular Pharmacology and Therapeutics, July 2015, SAGE Publications

Prof. Francisco Marin
sST2 levels are associated with all‐cause mortality in anticoagulated patients with atrial fibrillation

Article • European Journal of Clinical Investigation, July 2015, Wiley

Prof. Francisco Marin
Trichoderma saturnisporum, a new biological control agent

Article • Journal of the Science of Food and Agriculture, July 2015, Wiley

Prof. Francisco Marin
Novel biomarkers in cardiology: MicroRNAs in atrial fibrillation

Article • Archivos de Cardiología de México, July 2015, Publicidad Permanyer, SLU

Prof. Francisco Marin
The importance of excellence in the quality of anticoagulation control whilst taking vitamin K antagonists

Article • Thrombosis and Haemostasis, July 2015, Thieme Publishing Group

Prof. Francisco Marin
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Soc...

Article • EP Europace, June 2015, European Society of Cardiology

Prof. Francisco Marin
Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Socie...

Article • EP Europace, June 2015, European Society of Cardiology

Prof. Francisco Marin
Probing deformed commutators with macroscopic harmonic oscillators

Article • Nature Communications, June 2015, Springer Science + Business Media

Prof. Francisco Marin
De novo mutations in PLXND1 and REV3L cause Möbius syndrome

Article • Nature Communications, June 2015, Springer Science + Business Media

Prof. Francisco Marin
Simulating tropical forage growth and biomass accumulation: an overview of model development and application

Article • Grass and Forage Science, June 2015, Wiley

Prof. Francisco Marin
Importance of Sudden Cardiac Death Risk Stratification in Hypertrophic Cardiomyopathy

Article • Revista Española de Cardiología (English Edition), June 2015, Elsevier

Prof. Francisco Marin
Satisfaction With Medical Care in Patients With Atrial Fibrillation Treated With Vitamin K Antagonists Versus New Oral Anticoagulants

Article • Revista Española de Cardiología (English Edition), June 2015, Elsevier

Prof. Francisco Marin
Comparison of Estimated Glomerular Filtration Rate Equations for Dosing New Oral Anticoagulants in Patients With Atrial Fibrillation

Article • Revista Española de Cardiología (English Edition), June 2015, Elsevier

Prof. Francisco Marin
Quality of Anticoagulation With Vitamin K Antagonists

Article • Clinical Cardiology, May 2015, Wiley

Prof. Francisco Marin
Modulation of cholesterol-related gene expression by ergosterol and ergosterol-enriched extracts obtained from Agaricus bisporus

Article • European Journal of Nutrition, May 2015, Springer Science + Business Media

Prof. Francisco Marin
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

Article • American Heart Journal, May 2015, Elsevier

Professor Vladimir V Rafalskiy, Professor john j mcmurray, Professor Tzung-Dau Wang, Professor Rayaz Ahmed Malik, Prof. Francisco Marin
CALU polymorphism A29809G affects calumenin availability involving vascular calcification

Article • Journal of Molecular and Cellular Cardiology, May 2015, Elsevier

Jose Martinez Gonzalez, Dr Cristina Rodriguez, Prof. Francisco Marin
Ultrastructure of the Interlamellar Membranes of the Nacre of the Bivalve Pteria hirundo, Determined by Immunolabelling

Article • PLOS One, April 2015, PLOS

Prof. Francisco Marin
Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry p...

Article • American Heart Journal, April 2015, Elsevier

Prof. Francisco Marin
Spine and test skeletal matrices of the Mediterranean sea urchinArbacia lixula- a comparative characterization of their sugar signature

Article • European Journal of Biochemistry, March 2015, Wiley

Prof. Francisco Marin
Major bleeding risk prediction using Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease equations in acute coronary syndrome

Article • European Journal of Clinical Investigation, March 2015, Wiley

Prof. Francisco Marin
Update on Ischemic Heart Disease and Intensive Cardiac Care

Article • Revista Española de Cardiología (English Edition), March 2015, Elsevier

Prof. Francisco Marin
The test skeletal matrix of the black sea urchin Arbacia lixula

Article • Comparative Biochemistry and Physiology Part D Genomics and Proteomics, March 2015, Elsevier

Prof. Francisco Marin
Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis

Article • Osteoporosis International, February 2015, Springer Science + Business Media

Prof. Francisco Marin
Dysphagia Diagnosed by Fiberoptic Endoscopy Is Common and Transient in Critical Illness Polyneuropathy

Article • Critical Care Medicine, February 2015, Wolters Kluwer Health

Prof. Francisco Marin
Lactational exposure to low levels of the six indicator non-dioxin-like polychlorinated biphenyls induces DNA damage and repression of neuronal activity, in juvenile male mice

Article • Toxicology, February 2015, Elsevier

Prof. Francisco Marin
TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy

Article • European Journal of Clinical Investigation, January 2015, Wiley

Prof. Francisco Marin
Remarkable Proanthocyanidin Adsorption Properties of Monastrell Pomace Cell Wall Material Highlight Its Potential Use as an Alternative Fining Agent in Red Wine Production

Article • Journal of Agricultural and Food Chemistry, January 2015, American Chemical Society (ACS)

Prof. Francisco Marin
Involvement of the −420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy

Article • Journal of Internal Medicine, January 2015, Wiley

Prof. Francisco Marin
Effect of Selenium-Enriched Agaricus bisporus (Higher Basidiomycetes) Extracts, Obtained by Pressurized Water Extraction, on the Expression of Cholesterol Homeostasis Related Genes by Low-Density Array

Article • International Journal of Medicinal Mushrooms, January 2015, Begell House

Dr Arantxa Rodriguez-Casado, Prof. Francisco Marin
The search for optimal anticoagulation therapy in ACS: The gap between clinical trials and current clinical guidelines

Article • Thrombosis and Haemostasis, January 2015, Thieme Publishing Group

Prof. Francisco Marin
Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists

Article • Thrombosis and Haemostasis, January 2015, Thieme Publishing Group

Prof. Francisco Marin
Comments on the 2014 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism

Article • Revista Española de Cardiología (English Edition), January 2015, Elsevier

Prof. Francisco Marin
Oral Anticoagulation in Japanese Patients With Atrial Fibrillation

Article • Circulation Journal, January 2015, Japanese Circulation Society

Prof. Francisco Marin
Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State

Article • Journal of Atherosclerosis and Thrombosis, January 2015, Japan Atherosclerosis Society

Prof. Francisco Marin
Lone Atrial Fibrillation- A Diagnosis of Exclusion

Article • Current Pharmaceutical Design, December 2014, Bentham Science Publishers

Prof. Francisco Marin
GDF-15 and risk stratification in atrial fibrillation

Article • Nature Reviews Cardiology, November 2014, Springer Science + Business Media

Prof. Francisco Marin
Red Cell Distribution Width and Coronary Artery Disease. Response

Article • Revista Española de Cardiología (English Edition), November 2014, Elsevier

Prof. Francisco Marin
SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation

Article • The American Journal of Medicine, November 2014, Elsevier

Prof. Francisco Marin
Reactivity of pure and commercial grape skin tannins with cell wall material

Article • European Food Research and Technology, October 2014, Springer Science + Business Media

Prof. Francisco Marin
Red Cell Distribution Width and Additive Risk Prediction for Major Bleeding in Non–ST-segment Elevation Acute Coronary Syndrome

Article • Revista Española de Cardiología (English Edition), October 2014, Elsevier

Prof. Francisco Marin
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group ...

Article • European Heart Journal, August 2014, European Society of Cardiology

Prof HECTOR BUENO, Prof. Francisco Marin
Dynamic Prognostic Stratification in ST–elevation Myocardial Infarction. Response

Article • Revista Española de Cardiología (English Edition), July 2014, Elsevier

Prof. Francisco Marin
Methods of kidney function assessment in non-valvular atrial fibrillation in the era of new oral anticoagulants

Article • European Journal of Internal Medicine, July 2014, Elsevier

Prof. Francisco Marin
Recanalization and Mortality Rates of Thrombectomy With Stent-Retrievers in Octogenarian Patients with Acute Ischemic Stroke

Article • Cardiovascular Radiology, June 2014, Springer Science + Business Media

Prof. Francisco Marin
C0487: NT-proBNP Provided Complementary Prognostic Information to an Established Clinical Risk Score (CHA2DS2-VASc) for the Prediction of Stroke/Systemic Embolism

Article • Thrombosis Research, May 2014, Elsevier

Prof. Francisco Marin
Use of Antithrombotic Therapy in Patients With Atrial Fibrillation in Primary Care. Importance of INR Control

Article • Revista Española de Cardiología (English Edition), May 2014, Elsevier

Prof. Francisco Marin
Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin

Article • British Journal of Haematology, April 2014, Wiley

Prof. Francisco Marin
Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy

Article • QJM, March 2014, Oxford University Press (OUP)

Prof. Francisco Marin
Usefulness of N-Terminal Pro–B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation

Article • Stroke, March 2014, Wolters Kluwer Health

Prof. Francisco Marin
Update on Ischemic Heart Disease and Critical Care Cardiology

Article • Revista Española de Cardiología (English Edition), February 2014, Elsevier

Prof. Francisco Marin
Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation

Article • Thrombosis and Haemostasis, January 2014, Thieme Publishing Group

Prof. Francisco Marin
The optimal management of patients on oral anticoagulation undergoing coronary artery stenting

Article • Thrombosis and Haemostasis, January 2014, Thieme Publishing Group

Prof. Francisco Marin , Professor Deepak L Bhatt
Interleukin-6 as a predictor of cardiovascular events in troponin-negative non-ST elevation acute coronary syndrome patients

Article • International Journal of Clinical Practice, December 2013, Wiley

Prof. Francisco Marin
Biomarkers in atrial fibrillation: an overview

Article • International Journal of Clinical Practice, December 2013, Hindawi Publishing Corporation

Prof. Francisco Marin
The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation

Article • Journal of the American College of Cardiology, December 2013, Elsevier

Prof. Francisco Marin
β-Trace Protein and Prognosis in Patients With Atrial Fibrillation Receiving Anticoagulation Treatment

Article • CHEST Journal, November 2013, Elsevier

Prof. Francisco Marin
Manifestaciones neurológicas de los mixomas cardiacos. Experiencia en un centro de referencia

Article • Neurología, November 2013, Elsevier

Prof. Francisco Marin
High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery

Article • European Journal of Cardio-Thoracic Surgery, October 2013, Oxford University Press (OUP)

Prof. Francisco Marin
Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?

Article • Internal and Emergency Medicine, October 2013, Springer Science + Business Media

Prof. Francisco Marin
Role of microRNAs in cardiac remodelling: New insights and future perspectives

Article • International Journal of Cardiology, September 2013, Elsevier

Prof. Francisco Marin
N-terminal Pro-brain Natriuretic Peptide and High-sensitivity Troponin in the Evaluation of Acute Chest Pain of Uncertain Etiology. A PITAGORAS Substudy

Article • Revista Española de Cardiología (English Edition), July 2013, Elsevier

Prof. Francisco Marin
The complex role of bone turnover biomarkers in cardiovascular diseases

Article • European Journal of Heart Failure, June 2013, Wiley

Prof. Francisco Marin
Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches

Article • Annals of Medicine, May 2013, Taylor & Francis

Prof. Francisco Marin
Letter by Marín et al Regarding Article, “Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort Study”

Article • Circulation, April 2013, Wolters Kluwer Health

Prof. Francisco Marin
Renal Impairment in a “Real-Life” Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)

Article • The American Journal of Cardiology, April 2013, Elsevier

Prof. Francisco Marin
Small-size circulating microparticles in acute coronary syndromes: Relevance to fibrinolytic status, reparative markers and outcomes

Article • Atherosclerosis, April 2013, Elsevier

Prof. Francisco Marin
Interleukin-6 and High-sensitivity C-reactive Protein for the Prediction of Outcomes in Non-ST-segment Elevation Acute Coronary Syndromes

Article • Revista Española de Cardiología (English Edition), March 2013, Elsevier

Prof. Francisco Marin
Eco-Doppler de ejercicio en pacientes con miocardiopatía hipertrófica. Factores determinantes de la limitación funcional

Article • Revista Española de Cardiología, February 2013, Elsevier

Prof. Francisco Marin
-Trace Protein: From GFR Marker to Cardiovascular Risk Predictor

Article • Clinical Journal of the American Society of Nephrology, January 2013, American Society of Nephrology

Professor James Januzzi, Prof. Francisco Marin
Beta-Trace Protein and Cystatin C as Predictors of Major Bleeding in Non-ST-Segment Elevation Acute Coronary Syndrome

Article • Circulation Journal, January 2013, Japanese Circulation Society

Prof. Francisco Marin
Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy

Article • Thrombosis and Haemostasis, January 2013, Thieme Publishing Group

Prof. Francisco Marin
Tratamiento antitrombótico y tipo de stent en pacientes con fibrilación auricular a los que se practica una intervención coronaria percutánea

Article • Revista Española de Cardiología, January 2013, Elsevier

Prof. Francisco Marin
Antithrombotic therapy and bleeding risk in atrial fibrillation. Fewer unanswered questions

Article • Thrombosis and Haemostasis, January 2013, Thieme Publishing Group

Prof. Francisco Marin
Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

Article • Thrombosis and Haemostasis, January 2013, Thieme Publishing Group

Prof. Francisco Marin
Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

Article • Thrombosis and Haemostasis, January 2013, Thieme Publishing Group

Prof. Francisco Marin
Oral anticoagulation for heart failure in sinus rhythm: from evidence to clinical recommendations, or not?

Article • European Journal of Heart Failure, January 2013, Wiley

Prof. Francisco Marin
Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

Article • CHEST Journal, January 2013, Elsevier

Prof. Francisco Marin
The prognostic role of the adiponectin levels in atrial fibrillation

Article • European Journal of Clinical Investigation, December 2012, Wiley

Prof. Francisco Marin
Atherosclerosis and thromboembolic risk in atrial fibrillation: Focus on peripheral vascular disease

Article • Annals of Medicine, December 2012, Taylor & Francis

Prof. Francisco Marin
Prior aspirin therapy and cardiovascular implantable electronic device infections

Article • EP Europace, November 2012, European Society of Cardiology

Prof. Francisco Marin
High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: a reply to a rebuttal

Article • Journal of Thrombosis and Haemostasis, November 2012, Elsevier

Prof. Francisco Marin
Usefulness of β-Trace Protein and Cystatin C for the Prediction of Mortality in Non ST Segment Elevation Acute Coronary Syndromes

Article • The American Journal of Cardiology, November 2012, Elsevier

Prof. Francisco Marin
Comparative Determination and Monitoring of Biomarkers of Necrosis and Myocardial Remodeling between Radiofrequency Ablation and Cryoablation

Article • Pacing and Clinical Electrophysiology, October 2012, Wiley

Prof. Francisco Marin
Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation

Article • European Journal of Clinical Investigation, October 2012, Wiley

Prof. Francisco Marin
Pre and Post-Operative Treatments for Prevention of Atrial Fibrillation after Cardiac Surgery

Article • Mini-Reviews in Medicinal Chemistry, October 2012, Bentham Science Publishers

Prof. Francisco Marin
Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting

Article • Age and Ageing, September 2012, Oxford University Press (OUP)

Prof. Francisco Marin
Usefulness of high-sensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage

Article • American Heart Journal, August 2012, Elsevier

Prof. Francisco Marin
High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation

Article • Journal of Thrombosis and Haemostasis, August 2012, Elsevier

Prof. Francisco Marin
Should We Recommend Oral Anticoagulation Therapy in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting With a High HAS-BLED Bleeding Risk Score?

Article • Circulation Cardiovascular Interventions, August 2012, Wolters Kluwer Health

Prof. Francisco Marin
Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients

Article • Journal of Internal Medicine, July 2012, Wiley

Prof. Francisco Marin
Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis

Article • European Journal of Heart Failure, July 2012, Wiley

Professor john j mcmurray, Prof. Francisco Marin
Predictive Value of the CHA2DS2-VASc Score in Atrial Fibrillation Patients at High Risk for Stroke Despite Oral Anticoagulation

Article • Revista Española de Cardiología (English Edition), July 2012, Elsevier

Prof. Francisco Marin
Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable?

Article • Expert Opinion on Pharmacotherapy, May 2012, Informa Healthcare

Prof. Francisco Marin
Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation

Article • Circulation Arrhythmia and Electrophysiology, April 2012, Wolters Kluwer Health

Prof. Francisco Marin
Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy

Article • European Journal of Internal Medicine, March 2012, Elsevier

Prof. Francisco Marin
Influence of CYP2C19 Polymorphisms in Platelet Reactivity and Prognosis in an Unselected Population of Non ST Elevation Acute Coronary Syndrome

Article • Revista Española de Cardiología (English Edition), March 2012, Elsevier

Prof. Francisco Marin
Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders

Article • Current Pharmaceutical Design, February 2012, Bentham Science Publishers

Prof. Francisco Marin
CardioPulse Articles

Article • European Heart Journal, January 2012, European Society of Cardiology

Prof. Francisco Marin
New Perspectives in Antiplatelet Therapy

Article • Current Medicinal Chemistry, January 2012, Bentham Science Publishers

Prof. Francisco Marin
Edoxaban in Japanese Patients With Nonvalvular Atrial Fibrillation

Article • Circulation Journal, January 2012, Japanese Circulation Society

Prof. Francisco Marin
High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS

Article • The Scientific World JOURNAL, January 2012, Hindawi Publishing Corporation

Prof. Francisco Marin
Mild kidney disease as a risk factor for major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting

Article • Thrombosis and Haemostasis, January 2012, Thieme Publishing Group

Prof. Francisco Marin
New Evidence, New Controversies: a Critical Review of the European Society of Cardiology 2010 Clinical Practice Guidelines on Atrial Fibrillation

Article • Revista Española de Cardiología (English Edition), January 2012, Elsevier

Prof. Francisco Marin
Oral anticoagulation in chronic kidney disease: A huge challenge

Article • Thrombosis and Haemostasis, January 2012, Thieme Publishing Group

Prof. Francisco Marin
Primary Prevention With Aspirin in Type 2 Diabetic Patients

Article • Circulation Journal, January 2012, Japanese Circulation Society

Prof. Francisco Marin
Pro: “Antidote for new anticoagulants” – Specific target of inhibition requires a specific target for neutralisation

Article • Thrombosis and Haemostasis, January 2012, Thieme Publishing Group

Prof. Francisco Marin
Stroke and Thromboembolism in Atrial Fibrillation

Article • Circulation Journal, January 2012, Japanese Circulation Society

Prof. Francisco Marin
The ATRIA Risk Scheme to Predict Warfarin-Associated Hemorrhage

Article • Journal of the American College of Cardiology, January 2012, Elsevier

Prof. Francisco Marin
Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm

Article • Thrombosis and Haemostasis, January 2012, Thieme Publishing Group

Prof. Francisco Marin
Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?

Article • Thrombosis Research, December 2011, Elsevier

Prof. Francisco Marin
A New Landscape for Stroke Prevention in Atrial Fibrillation

Article • Stroke, November 2011, Wolters Kluwer Health

Prof. Francisco Marin
Prevención de complicaciones hemorrágicas en el síndrome coronario agudo

Article • Medicina Clínica, November 2011, Elsevier

Prof. Francisco Marin
Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: A pilot study

Article • Thrombosis Research, October 2011, Elsevier

Prof. Francisco Marin
The Improved but Unfinished Business of Stroke Risk Stratification in Atrial Fibrillation

Article • Revista Española de Cardiología (English Edition), August 2011, Elsevier

Prof. Francisco Marin
Prognostic Value of Mean Platelet Volume in Patients With Non-ST-Elevation Acute Coronary Syndrome

Article • Angiology, July 2011, SAGE Publications

Prof. Francisco Marin
An Insight of Novel Pharmacological Therapies in Hypertrophic Cardiomyopathy

Article • Medicinal Chemistry, July 2011, Bentham Science Publishers

Prof. Francisco Marin
Circulating microparticles: new insights into the biochemical basis of microparticle release and activity

Article • Basic Research in Cardiology, June 2011, Springer Science + Business Media

Prof. Francisco Marin
Interactions Between Clopidogrel and Proton Pump Inhibitors: A Review of Evidence

Article • Current Medicinal Chemistry, June 2011, Bentham Science Publishers

Prof. Francisco Marin
Plasma von Willebrand Factor Levels Are an Independent Risk Factor for Adverse Events Including Mortality and Major Bleeding in Anticoagulated Atrial Fibrillation Patients

Article • Journal of the American College of Cardiology, June 2011, Elsevier

Prof. Francisco Marin
An Evaluation of the CHADS2 Stroke Risk Score in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Revascularization

Article • CHEST Journal, June 2011, Elsevier

Prof. Francisco Marin
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

Article • EP Europace, April 2011, European Society of Cardiology

Prof. Francisco Marin
Impact of polymorphisms in the renin–angiotensin–aldosterone system on hypertrophic cardiomyopathy

Article • Journal of the Renin-Angiotensin-Aldosterone System, April 2011, SAGE Publications

Prof. Francisco Marin
Peri-operative management of ophthalmic patients taking antithrombotic therapy

Article • International Journal of Clinical Practice, February 2011, Hindawi Publishing Corporation

Prof. Francisco Marin
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe

Article • Thrombosis and Haemostasis, January 2011, Thieme Publishing Group

Prof. Francisco Marin
Bleeding risk assessment and management in atrial fibrillation patients

Article • Thrombosis and Haemostasis, January 2011, Thieme Publishing Group

Prof. Francisco Marin
Collagen peptides, interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy

Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2011, De Gruyter

Prof. Francisco Marin
Serum Levels of High-Sensitivity Troponin T: A Novel Marker for Cardiac Remodeling in Hypertrophic Cardiomyopathy

Article • Journal of Cardiac Failure, December 2010, Elsevier

Prof. Francisco Marin
Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin?

Article • EP Europace, October 2010, European Society of Cardiology

Prof. Francisco Marin
The prognostic value of biomarkers after a premature myocardial infarction

Article • International Journal of Cardiology, September 2010, Elsevier

Prof. Francisco Marin
Rhythm control agents and adverse events in patients with atrial fibrillation

Article • International Journal of Clinical Practice, August 2010, Hindawi Publishing Corporation

Prof. Francisco Marin
Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk

Article • Annals of Medicine, August 2010, Taylor & Francis

Prof. Francisco Marin
CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis

Article • Annals of Medicine, August 2010, Taylor & Francis

Prof. Francisco Marin
Plasma levels of Von Willebrand factor are increased in patients with hypertrophic cardiomyopathy

Article • Thrombosis Research, July 2010, Elsevier

Prof. Francisco Marin
Enzyme Replacement Therapy in Fabry Disease: Influence on Cardiac Manifestations

Article • Current Medicinal Chemistry, June 2010, Bentham Science Publishers

Prof. Francisco Marin
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed b...

Article • European Heart Journal, May 2010, European Society of Cardiology

Prof. Francisco Marin
Hypouricemic effect of statins: Another pleiotropic benefit?

Article • Journal of Thoracic and Cardiovascular Surgery, May 2010, Elsevier

Prof. Francisco Marin
Effects of atorvastatin 80 mg daily on indices of matrix remodelling in ‘high-risk’ patients with ischemic heart disease

Article • International Journal of Cardiology, February 2010, Elsevier

Prof. Francisco Marin
The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?

Article • Heart, February 2010, BMJ

Prof. Francisco Marin
Glycoprotein inhibitors in patients on chronic anticoagulation: Safe enough or too much risk?

Article • Thrombosis and Haemostasis, January 2010, Thieme Publishing Group

Prof. Francisco Marin
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

Article • Thrombosis and Haemostasis, January 2010, Thieme Publishing Group

Prof. Francisco Marin
Synergism between factor XII –4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

Article • Thrombosis and Haemostasis, January 2010, Thieme Publishing Group

Prof. Francisco Marin
Miocardiopatía hipertrófica. Estudio del gen de la troponina T en 127 familias españolas

Article • Revista Española de Cardiología, December 2009, Elsevier

Prof. Francisco Marin
¿Existe un efecto beneficioso a largo plazo con el tratamiento con marcapasos de la miocardiopatía hipertrófica obstructiva severa?

Article • Revista Española de Cardiología, November 2009, Elsevier

Prof. Francisco Marin
Biomarcadores en la estratificación del riesgo del síndrome coronario agudo sin elevación del segmento ST: ¿hay algo más después de la troponina?

Article • Medicina Clínica, October 2009, Elsevier

Prof. Francisco Marin
Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling

Article • International Journal of Clinical Practice, October 2009, Hindawi Publishing Corporation

Prof. Francisco Marin
Pharmacogenetics in Cardiovascular Antithrombotic Therapy

Article • Journal of the American College of Cardiology, September 2009, Elsevier

Prof. Francisco Marin
Premature coronary artery disease in young (age < 45) subjects: Interactions of lipid profile, thrombophilic and haemostatic markers

Article • International Journal of Cardiology, August 2009, Elsevier

Prof. Francisco Marin
Implications of Pharmacogenetics for Oral Anticoagulants Metabolism

Article • Current Drug Metabolism, July 2009, Bentham Science Publishers

Prof. Francisco Marin
Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence

Article • EP Europace, June 2009, European Society of Cardiology

Prof. Francisco Marin
“Antithrombotic therapy after coronary stenting in patients with indication for oral anticoagulation”

Article • International Journal of Cardiology, May 2009, Elsevier

Prof. Francisco Marin
Does the Holy Grail escape us again?

Article • European Heart Journal, April 2009, European Society of Cardiology

Prof. Francisco Marin
Impact of Chronic Kidney Disease on Major Bleeding Complications and Mortality in Patients With Indication for Oral Anticoagulation Undergoing Coronary Stenting

Article • CHEST Journal, April 2009, Elsevier

Prof. Francisco Marin
Dispersión del intervalo QT y miocardio viable

Article • Revista Española de Cardiología, April 2009, Elsevier

Prof. Francisco Marin
Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation

Article • International Journal of Cardiology, February 2009, Elsevier

Prof. Francisco Marin
Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis

Article • Thrombosis and Haemostasis, January 2009, Thieme Publishing Group

Prof. Francisco Marin
Is thrombogenesis related to residual platelet function in ischaemic heart disease?

Article • European Heart Journal, October 2008, European Society of Cardiology

Prof. Francisco Marin
Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation

Article • European Heart Journal, September 2008, European Society of Cardiology

Prof. Francisco Marin
Endothelial protein C receptor polymorphisms and risk of myocardial infarction

Article • Haematologica, September 2008, Ferrata Storti Foundation (Haematologica)

Prof. Francisco Marin
Increased Major Bleeding Complications Related to Triple Antithrombotic Therapy Usage in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Artery Stenting

Article • CHEST Journal, September 2008, Elsevier

Prof. Francisco Marin
Hypertension, aortic sclerosis and the prothrombotic state: understanding the complex interaction

Article • Journal of Human Hypertension, August 2008, Springer Science + Business Media

Prof. Francisco Marin
The impact of statin use on atrial fibrillation

Article • QJM, July 2008, Oxford University Press (OUP)

Prof. Francisco Marin
Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy

Article • American Heart Journal, July 2008, Elsevier

Prof. Francisco Marin
Antithrombotic Therapy Use After Percutaneous Coronary Intervention and Stent Implantation in Patients Taking Chronic Oral Anticoagulation

Article • JACC Cardiovascular Interventions, June 2008, Elsevier

Prof. Francisco Marin
Variables Associated With Contrast-Enhanced Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy: Clinical Implications

Article • Journal of Cardiac Failure, June 2008, Elsevier

Prof. Francisco Marin
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis

Article • European Heart Journal, May 2008, European Society of Cardiology

Prof. Francisco Marin
AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms

Article • Haematologica, May 2008, Ferrata Storti Foundation (Haematologica)

Prof. Francisco Marin
Reply

Article • Journal of the American College of Cardiology, May 2008, Elsevier

Prof. Francisco Marin
Premature myocardial infarction: Clinical profile and angiographic findings

Article • International Journal of Cardiology, May 2008, Elsevier

Prof. Francisco Marin
Unable to speak—because of a drip

Article • The Lancet, May 2008, Elsevier

Prof. Francisco Marin
Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting

Article • QJM, March 2008, Oxford University Press (OUP)

Prof. Francisco Marin
Mortality in patients with atrial fibrillation: improving or not?

Article • EP Europace, March 2008, European Society of Cardiology

Prof. Francisco Marin
Short- and long-term effects of growth hormone on the heart

Article • International Journal of Cardiology, March 2008, Elsevier

Prof. Francisco Marin
Letter by Roldán et al Regarding Article, “Plasminogen Activator Inhibitor-1 as a Predictor of Postoperative Atrial Fibrillation After Cardiopulmonary Bypass”

Article • Circulation, February 2008, Wolters Kluwer Health

Prof. Francisco Marin
Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation

Article • Journal of the American College of Cardiology, February 2008, Elsevier

Prof. Francisco Marin
Gadolinium-Enhanced Cardiovascular Magnetic Resonance and Exercise Capacity in Hypertrophic Cardiomyopathy

Article • Revista Española de Cardiología (English Edition), January 2008, Elsevier

Prof. Francisco Marin
Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'

Article • Thrombosis and Haemostasis, January 2008, Thieme Publishing Group

Prof. Francisco Marin
Factor VII –323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

Article • Annals of Medicine, January 2008, Taylor & Francis

Prof. Francisco Marin
Is There a Role for Levosimendan in Hospital Emergency Departments?

Article • Revista Española de Cardiología (English Edition), January 2008, Elsevier

Prof. Francisco Marin
TUBB1 Q43P polymorphism does not protect against acute coronary syndrome and premature myocardial infarction

Article • Thrombosis and Haemostasis, January 2008, Thieme Publishing Group

Prof. Francisco Marin
Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy

Article • Journal of the American College of Cardiology, December 2007, Elsevier

Prof. Francisco Marin
A multimarker risk stratification approach to non‐ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro‐BNP and fibrin D‐dimer levels

Article • Journal of Internal Medicine, November 2007, Wiley

Prof. Francisco Marin
Plasma angiogenin levels in acute coronary syndromes: implications for prognosis

Article • European Heart Journal, November 2007, European Society of Cardiology

Prof. Francisco Marin
Respuesta

Article • Revista Española de Cardiología, July 2007, Elsevier

Prof. Francisco Marin
Matrix metalloproteinase‐1 and its inhibitor, TIMP‐1, in systolic heart failure: relation to functional data and prognosis

Article • Journal of Internal Medicine, June 2007, Wiley

Prof. Francisco Marin
Coronary aneurysms after drug-eluting stents implantation

Article • European Heart Journal, June 2007, European Society of Cardiology

Prof. Francisco Marin
Pharmacologic Therapy in Growth Hormone Disorders and the Heart

Article • Current Medicinal Chemistry, June 2007, Bentham Science Publishers

Prof. Francisco Marin
Prognostic value of annexin A5 −1 C/T polymorphism in a long term follow‐up after premature myocardial infarction

Article • Journal of Thrombosis and Haemostasis, April 2007, Elsevier

Prof. Francisco Marin
Common Carotid Artery Intima-Media Thickness and Intracranial Pulsatility Index in Non-ST-Elevation Acute Coronary Syndromes

Article • Cerebrovascular Diseases, January 2007, Karger Publishers

Prof. Francisco Marin
Effect of Statins on Preventing Recurrence of Atrial Fibrillation After Electrical Cardioversion

Article • The American Journal of Cardiology, November 2006, Elsevier

Prof. Francisco Marin
Antiplatelet versus anticoagulant therapies in advanced age: An unfinished task

Article • International Journal of Cardiology, June 2006, Elsevier

Prof. Francisco Marin
Atrial stunning as predictor of early relapse into atrial fibrillation after cardioversion

Article • International Journal of Cardiology, June 2006, Elsevier

Prof. Francisco Marin
Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?

Article • International Journal of Cardiology, June 2006, Elsevier

Prof. Francisco Marin
Desfibrilador automático en la miocardiopatía hipertrófica. Experiencia de 3 centros

Article • Revista Española de Cardiología, June 2006, Elsevier

Prof. Francisco Marin
Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?

Article • Journal of Thrombosis and Thrombolysis, April 2006, Springer Science + Business Media

Prof. Francisco Marin
Growth Hormone Therapy and the Heart

Article • The American Journal of Cardiology, April 2006, Elsevier

Prof. Francisco Marin
Fluctuations in Coagulation Activity Among Patients with Atrial Fibrillation who are Stably Anticoagulated

Article • Future Cardiology, February 2006, Taylor & Francis

Prof. Francisco Marin
Statins and Postoperative Risk of Atrial Fibrillation Following Coronary Artery Bypass Grafting

Article • The American Journal of Cardiology, January 2006, Elsevier

Prof. Francisco Marin
Cardiac tamponade following pacemaker implantation

Article • International Journal of Cardiology, October 2005, Elsevier

Prof. Francisco Marin
Efecto de dosis máximas de atorvastatina en la inflamación, la trombogénesis y la función fibrinolítica en pacientes con cardiopatía isquémica de alto riesgo

Article • Revista Española de Cardiología, August 2005, Elsevier

Prof. Francisco Marin
Polimorfismos en la región Kozak del FXII y su relación con el infarto agudo de miocardio prematuro

Article • Clínica e Investigación en Arteriosclerosis, June 2005, Elsevier

Prof. Francisco Marin
Are there ethnic differences in the circadian variation in onset of acute myocardial infarction?

Article • International Journal of Cardiology, April 2005, Elsevier

Prof. Francisco Marin
Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation

Article • The American Journal of Cardiology, April 2005, Elsevier

Prof. Francisco Marin
Plasma Concentration of Big Endothelin-1 and Its Relation With Plasma NT-proBNP and Ventricular Function in Heart Failure Patients

Article • Revista Española de Cardiología (English Edition), March 2005, Elsevier

Prof. Francisco Marin
Influence of smoking habit on cardiac functional capacity and diastolic function in healthy people

Article • International Journal of Cardiology, February 2005, Elsevier

Prof. Francisco Marin
Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation

Article • Thrombosis Research, January 2005, Elsevier

Prof. Francisco Marin
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction

Article • Journal of the American College of Cardiology, January 2005, Elsevier

Prof. Francisco Marin
Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction

Article • Thrombosis and Haemostasis, January 2005, Thieme Publishing Group

Prof. Francisco Marin
Effect of factor VII −323 Del/Ins polymorphism on the daily variability of factor VIIc and INR in steady anticoagulated patients with acenocoumarol

Article • Journal of Thrombosis and Haemostasis, December 2004, Elsevier

Prof. Francisco Marin
Can We Expect Polymorphisms to Answer our Questions?

Article • Revista Española de Cardiología (English Edition), November 2004, Elsevier

Prof. Francisco Marin
Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction

Article • American Heart Journal, October 2004, Elsevier

Prof. Francisco Marin
Genetic Polymorphisms and Thromoembolic Risk in Atrial Fibrillation

Article • Journal of Thrombosis and Thrombolysis, October 2004, Springer Science + Business Media

Prof. Francisco Marin
Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation

Article • Journal of Molecular and Cellular Cardiology, September 2004, Elsevier

Prof. Francisco Marin
Are we content with lowering blood pressure alone, or should we be asking something more from the antihypertensive drugs we use?: effects of antihypertensive agents on fibrinolytic function

Article • Journal of Human Hypertension, June 2004, Springer Science + Business Media

Prof. Francisco Marin
NT-proBNP Levels and Hypertension. Their Importance in the Diagnosis of Heart Failure

Article • Revista Española de Cardiología (English Edition), May 2004, Elsevier

Prof. Francisco Marin
Effects of Pretreatment with Intravenous Flecainide on Efficacy of External Cardioversion of Persistent Atrial Fibrillation

Article • Pacing and Clinical Electrophysiology, March 2004, Wiley

Prof. Francisco Marin
Hypoxemia and Stroke in a Patient With a Pacemaker

Article • Revista Española de Cardiología (English Edition), March 2004, Elsevier

Prof. Francisco Marin
Growth Hormone Therapy , Is it Always Good for the Heart?

Article • European Heart Journal, January 2004, European Society of Cardiology

Prof. Francisco Marin
Matrix metalloproteinases in atrial fibrillation

Article • Journal of the American College of Cardiology, January 2004, Elsevier

Prof. Francisco Marin
Fractional shortening-velocity ratio for assessment of aortic stenosis severity in patients with systolic dysfunction

Article • International Journal of Cardiology, December 2003, Elsevier

Prof. Francisco Marin
NT-proBNP y desplazamiento del plano auriculoventricular. Relación e implicaciones diagnósticas

Article • Revista Española de Cardiología, November 2003, Elsevier

Prof. Francisco Marin
Heart valve disease in acromegaly

Article • International Journal of Cardiology, August 2003, Elsevier

Prof. Francisco Marin
Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation

Article • European Heart Journal, July 2003, European Society of Cardiology

Prof. Francisco Marin
Angiogénesis y estatinas, ¿a mayor dosis, mayor beneficio?

Article • Revista Española de Cardiología, June 2003, Elsevier

Prof. Francisco Marin
Is Thrombogenesis in Atrial Fibrillation Related to Matrix Metalloproteinase-1 and Its Inhibitor, TIMP-1?

Article • Stroke, May 2003, Wolters Kluwer Health

Prof. Francisco Marin
Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction

Article • The American Journal of Cardiology, May 2003, Elsevier

Prof. Francisco Marin
Fibrinolytic function and atrial fibrillation

Article • Thrombosis Research, March 2003, Elsevier

Prof. Francisco Marin
1438 Hypercoagulable state detected in atrial fibrillation patients is unrelated to clinical predictors to embolism

Article • European Heart Journal, March 2003, Elsevier

Prof. Francisco Marin
277 Is there quality of life improvement after upgrading to dual-chamber pacing in patients with VVI pacemakers?

Article • European Heart Journal, March 2003, Elsevier

Prof. Francisco Marin
Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer levels in acute-onset nonrheumatic atrial fibrillation

Article • Journal of the American College of Cardiology, March 2003, Elsevier

Prof. Francisco Marin
Valor pron&oacute;stico de los niveles s&eacute;ricos del factor de necrosis tumoral alfa en pacientes con insuficiencia card&iacute;aca

Article • Revista Española de Cardiología, February 2003, Elsevier

Prof. Francisco Marin
Soluble E-selectin in cardiovascular disease and its risk factors

Article • Thrombosis and Haemostasis, January 2003, Thieme Publishing Group

Prof. Francisco Marin
Diurnal variation of international normalised ratio in patients under oral anticoagulation

Article • Thrombosis Research, December 2002, Elsevier

Prof. Francisco Marin
Cardiac involvement in Fabry disease

Article • Acta Paediatrica, November 2002, Wiley

Prof. Francisco Marin
A common polymorphism in the annexin V Kozak sequence (−1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

Article • Blood, September 2002, American Society of Hematology

Prof. Francisco Marin
Prothrombin fragment F1+2 and von Willebrand factor levels and left ventricular systolic function. Peripheral versus intracardiac blood samples

Article • International Journal of Cardiology, June 2002, Elsevier

Prof. Francisco Marin
Do protein Z levels influence the prothrombotic state in atrial fibrillation?

Article • Thrombosis Research, May 2002, Elsevier

Prof. Francisco Marin
Low QRS voltage in cardiac tamponade: a study of 70 cases

Article • International Journal of Cardiology, April 2002, Elsevier

Prof. Francisco Marin
The role of tissue plasminogen activator on the progression of the coronary disease

Article • European Heart Journal, January 2002, European Society of Cardiology

Prof. Francisco Marin
Anexina V en pacientes supervivientes de un infarto de miocardio prematuro

Article • Revista Española de Cardiología, January 2002, Elsevier

Prof. Francisco Marin
Diurnal Variation in the Intensity of Anticoagulation in Atrial Fibrillation

Article • Stroke, January 2002, Wolters Kluwer Health

Prof. Francisco Marin
Effect of Factor XIII VAL34LEU Polymorphism on Thrombolytic Therapy in Premature Myocardial Infarction

Article • Thrombosis and Haemostasis, January 2002, Thieme Publishing Group

Prof. Francisco Marin
Polimorfismo Val34Leu del factor XIII e infarto de miocardio prematuro

Article • Revista Española de Cardiología, January 2002, Elsevier

Prof. Francisco Marin
Infrautilización del tratamiento anticoagulante en pacientes con fibrilación auricular

Article • Medicina Clínica, January 2002, Elsevier

Prof. Francisco Marin
Tissue factor/tissue factor pathway inhibitor system and long-term prognosis after acute myocardial infarction

Article • International Journal of Cardiology, April 2001, Elsevier

Prof. Francisco Marin
Anticoagulant Therapy Modifies Fibrinolytic Dysfunction in Chronic Atrial Fibrillation

Article • Pathophysiology of Haemostasis and Thrombosis, January 2000, Karger Publishers

Prof. Francisco Marin
Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation

Article • The American Journal of Cardiology, October 1999, Elsevier

Prof. Francisco Marin
Acute cardiac rupture complicating pre-discharge exercise testing. A case report with complete echocardiographic follow-up

Article • International Journal of Cardiology, March 1999, Elsevier

Prof. Francisco Marin
Hypofibrinolysis in atrial fibrillation

Article • American Heart Journal, December 1998, Elsevier

Prof. Francisco Marin
Antiplatelet Therapy in Stroke Prevention

Article • January 1992, Springer Science + Business Media

Prof. Francisco Marin

Search Kudos

Main menu

Discover

Subjects on Kudos

Services and resources

Admin

All Stories